Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26349
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMyers, Kenneth A-
dc.contributor.authorMarini, Carla-
dc.contributor.authorCarvill, Gemma L-
dc.contributor.authorMcTague, Amy-
dc.contributor.authorPanetta, Julie-
dc.contributor.authorStutterd, Chloe A-
dc.contributor.authorStanley, Thorsten-
dc.contributor.authorMarin, Samantha-
dc.contributor.authorNguyen, John-
dc.contributor.authorBarba, Carmen-
dc.contributor.authorRosati, Anna-
dc.contributor.authorScott, Richard H-
dc.contributor.authorMefford, Heather C-
dc.contributor.authorGuerrini, Renzo-
dc.contributor.authorScheffer, Ingrid E-
dc.date2021-03-18-
dc.date.accessioned2021-05-03T05:19:39Z-
dc.date.available2021-05-03T05:19:39Z-
dc.date.issued2021-04-
dc.identifier.citationNeurology. Genetics 2021; 7(2): e579en
dc.identifier.issn2376-7839
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26349-
dc.description.abstractTo describe the phenotypic spectrum in patients with MBD5-associated neurodevelopmental disorder (MAND) and seizures; features of MAND include intellectual disability, epilepsy, psychiatric features of aggression and hyperactivity, and dysmorphic features including short stature and microcephaly, sleep disturbance, and ataxia. We performed phenotyping on patients with MBD5 deletions, duplications, or point mutations and a history of seizures. Twenty-three patients with MAND and seizures were included. Median seizure onset age was 2.9 years (range 3 days-13 years). The most common seizure type was generalized tonic-clonic; focal, atypical absence, tonic, drop attacks, and myoclonic seizures occurred frequently. Seven children had convulsive status epilepticus and 3 nonconvulsive status epilepticus. Fever, viral illnesses, and hot weather provoked seizures. EEG studies in 17/21 patients were abnormal, typically showing slow generalized spike-wave and background slowing. Nine had drug-resistant epilepsy, although 3 eventually became seizure-free. All but one had moderate-to-severe developmental impairment. Epilepsy syndromes included Lennox-Gastaut syndrome, myoclonic-atonic epilepsy, and infantile spasms syndrome. Behavioral problems in 20/23 included aggression, self-injurious behavior, and sleep disturbance. MBD5 disruption may be associated with severe early childhood-onset developmental and epileptic encephalopathy. Because neuropsychiatric dysfunction is common and severe, it should be an important focus of clinical management.en
dc.language.isoeng
dc.titlePhenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder.en
dc.typeJournal Articleen
dc.identifier.journaltitleNeurology. Geneticsen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.affiliationChild Neurology and Psychiatry, Salesi Pediatric Hospital, United Hospitals of Ancona, Ancona, Italyen
dc.identifier.affiliationDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WAen
dc.identifier.affiliationDepartment of Neurology, Great Ormond Street Hospital for Children, London, UKen
dc.identifier.affiliationDevelopmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, UKen
dc.identifier.affiliationNeurology Network Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationMurdoch Children's Research Institute, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Paediatrics and Child Health, School of Medicine and Health Sciences, University of Otago, Wellington, New Zealanden
dc.identifier.affiliationDivision of Neurology, Department of Pediatrics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canadaen
dc.identifier.affiliationNeurology Unit and Neurogenetic Laboratories, Meyer Children's Hospital, Florence, Italyen
dc.identifier.affiliationDepartment of Clinical Genetics, Great Ormond Street Hospital, London, UKen
dc.identifier.affiliationEpilepsy Research Centreen
dc.identifier.affiliationDepartment of Paediatrics, Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationResearch Institute of the McGill University Health Centre, Montreal, PQen
dc.identifier.affiliationDivision of Child Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, PQen
dc.identifier.affiliationDepartment of Neurology & Neurosurgery, Montreal Children's Hospital, McGill University, Montreal, PQen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.doi10.1212/NXG.0000000000000579en
dc.type.contentTexten
dc.identifier.orcid0000-0001-7831-4593en
dc.identifier.orcid0000-0002-9212-2691en
dc.identifier.orcid0000-0003-4945-3628en
dc.identifier.orcid0000-0002-0334-2909en
dc.identifier.orcid0000-0002-2525-1936en
dc.identifier.orcid0000-0002-9862-7770en
dc.identifier.orcid0000-0001-5445-5842en
dc.identifier.orcid0000-0002-7272-7079en
dc.identifier.orcid0000-0002-2311-2174en
dc.identifier.pubmedid33912662
local.name.researcherScheffer, Ingrid E
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptClinical Genetics-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

72
checked on Jan 2, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.